|
2025
|
P/S
|
pharmaceutical substances and preparations for human use; biopharmaceutical substances and prepar... |
|
|
P/S
|
Pharmaceutical substances and preparations for human use; Biopharmaceutical substances and prepar... |
|
2024
|
Invention
|
Novel compounds and pharmaceutical compositions thereof for the treatment of infectious diseases.... |
|
|
Invention
|
Compounds and pharmaceutical compositions thereof for the treatment of diseases. 11, R1, R2, R3, ... |
|
|
Invention
|
Compounds and pharmaceutical compositions thereof for the treatment of diseases. 122, R1, and R2 ... |
|
|
Invention
|
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorde... |
|
|
Invention
|
Antibodies for il-17c.
The present invention provides antibodies or antibody fragments binding t... |
|
|
Invention
|
Pharmaceutical compositions and solid forms of compound 1 with fumarate for the treatment of infl... |
|
|
Invention
|
Imidazo[4,5-b]pyridine derivatives useful for the treatment of allergic diseases, inflammatory di... |
|
2023
|
P/S
|
Pharmaceutical substances and preparations for human use for the treatment of bone cartilage and ... |
|
|
P/S
|
Pharmaceutical substances and preparations for human use;
biopharmaceutical substances and prepa... |
|
|
Invention
|
Compounds and pharmaceutical compositions thereof for the treatment of neurodegenerative disorder... |
|
|
Invention
|
Sulfonamide compounds and pharmaceutical compositions thereof for the treatment of neurodegenerat... |
|
|
P/S
|
Software used as medical monitoring and control tool;
software as a medical device [SaMD]; compu... |
|
|
P/S
|
Software used as medical monitoring and control tool;
software as a medical device [samd]; compu... |
|
|
Invention
|
Compound for use in and methods of treatment of inflammatory diseases. The present invention rela... |
|
|
P/S
|
Pharmaceutical substances and preparations for human use, namely, pharmaceutical preparations and... |
|
2022
|
Invention
|
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders.
T... |
|
|
P/S
|
recorded software used as medical monitoring and control tool, specifically, software that coordi... |
|
|
P/S
|
Pharmaceutical substances and preparations for human use; biopharmaceutical substances and prepar... |
|
|
P/S
|
Software used as medical monitoring and control tool; Software as a medical device [SaMD]; Comput... |
|
|
Invention
|
Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases. ... |
|
|
Invention
|
Treatment of inflammatory diseases.
The present invention relates to new and improved methods fo... |
|
|
Invention
|
Treatment of inflammatory diseases. The present invention relates to new and improved methods for... |
|
|
Invention
|
Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods... |
|
2021
|
Invention
|
Solid forms of (5s)-cyclopropyl-5-[3-[(3s)-4-(3,5-difluorophenyl)-3-methyl-piperazin-1-yl]-3-oxo-... |
|
|
Invention
|
Novel isoquinoline derivatives and pharmaceutical copositions thereof for the treatment of diseas... |
|
|
Invention
|
Compound for use in and methods of treatment of fibrotic diseases.
The present invention relates... |
|
|
Invention
|
Compound for use in and methods of treatment of fibrotic diseases. The present invention relates ... |
|
|
Invention
|
Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment ... |
|
|
Invention
|
Pyrrolopyrimidine and pyrrolopyridine derivatives.
The present invention relates to pyrrolopyrim... |
|
|
Invention
|
Isoquinoline derivatives and pharmaceutical compositions thereof for the treatment of diseases. T... |
|
|
Invention
|
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use.... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
Invention
|
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for th... |
|
2020
|
Invention
|
Substantially pure clarithromycin 9-oxime and its preparation thereof.
The present invention rel... |
|
|
Invention
|
Substantially pure clarithromycin 9-oxime and its preparation thereof. EZEE)-oxime of formula (I)... |
|
|
P/S
|
Education services, namely, organizing and conducting conferences, seminars, workshops and classe... |
|
|
Invention
|
Pyrazolo[4,3-c]pyridine derivatives and pharmaceutical compositions thereof for the treatment of ... |
|
|
Invention
|
Novel compounds and pharmaceutical compositions thereof for the treatment of diseases. The presen... |
|
|
Invention
|
Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis b. The pre... |
|
|
Invention
|
Methods for the treatment of polycystic kidney disease. The present invention discloses compounds... |
|
|
Invention
|
Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases. The... |
|
|
Invention
|
Pyrazolopyridine derivatives as inhibitors of pask.
The present invention discloses compounds ac... |
|
|
Invention
|
Fused pyrimidine compounds and pharmaceutical compositions thereof for the treatment of fibrotic ... |
|
|
Invention
|
Pyrazolopyridine derivatives as inhibitors of pask. The present invention discloses compounds acc... |
|
2019
|
Invention
|
Methods of administering therapy.
The present invention relates to improved methods of administe... |
|
2018
|
Invention
|
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders. Th... |
|
|
P/S
|
pharmaceutical substances and preparations for human use, namely, for the treatment of bone carti... |
|
|
P/S
|
Pharmaceutical substances and preparations for human use namely, for the treatment of bone cartil... |
|
|
Invention
|
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis.
The prese... |
